To benefit from data protection in Canada, a drug must meet the definition of “innovative drug” under the Food and Drug Regulations.
Register Now As you are not an existing subscriber please register for your free daily legal newsfeed service.Register
If you have any questions about the service please contact firstname.lastname@example.org or call Lexology Customer Services on +44 20 7234 0606.
Innovative drugs sold under the special access programme can receive data protection in Canada
To view this article you need a PDF viewer such as Adobe Reader.
If you are interested in submitting an article to Lexology, please contact Andrew Teague at email@example.com.